Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

10$ Bargeld verdienen fĂŒr jeden Pro+ Freund, den du empfiehlst!

Bluebird bio Inc

Bluebird bio Inc

BLUE · NASDAQ
BLUE · NASDAQ
4.57
USD-0.40-8.14%

Datum

Ticker

Überschrift

Quelle

    Carlyle, SK Capital Partners disclose expected closing date of bluebird bio deal

    SeekingAlpha

      Bluebird bio soars on amended deal with Carlyle, SK Capital

      SeekingAlpha

        bluebird bio confirms Ayrmid has not delivered binding offer, shares dive 9%

        SeekingAlpha

          Key deals this week: xAI acquires X; bluebird bio, Nvidia, Dollar Tree and more

          SeekingAlpha

            bluebird bio sees higher offer for company from Ayrmid Pharma

            SeekingAlpha

              bluebird bio stock slides for second day on buyout news

              SeekingAlpha

                Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker - CNBC

                CNBC

                  bluebird bio announces take-private deal with Carlyle and SK Capital

                  SeekingAlpha

                    U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorder https://t.co/OTr4kvA3qD https://t.co/KitFoElcaz

                    Reuters
                    @Reuters

                      U.S. FDA approves Bluebird bio's gene therapy for a rare neurological disorder https://t.co/eDvQRLmxIj https://t.co/hKzFYtXraI

                      Reuters
                      @Reuters

                        Dow Jones Newswires: Bluebird Bio stock rises 62%, FDA committee supports treatments

                        MarketWatch

                          Bluebird bio's gene therapy for blood disorder gets FDA panel backing https://t.co/zLG8Sbj6KK https://t.co/JwcXiI3fIh

                          Reuters
                          @Reuters

                            Bluebird Bio's gene therapy for neurological disorder gets FDA panel backing https://t.co/5YWc7ccO2n https://t.co/M1JNHZFPS6

                            Reuters
                            @Reuters

                              Bluebird Bio's gene therapy for neurological disorder gets FDA panel backing https://t.co/4bUDXmkyR8 https://t.co/Ml1epCYesn

                              Reuters
                              @Reuters

                                Bluebird bio's blood disorder therapy effective - FDA staff https://t.co/O6ExtMNx8K https://t.co/MjfliLNyXn

                                Reuters
                                @Reuters

                                  Stocks making the biggest moves in the premarket: Activision Blizzard, Astra Space, Bluebird Bio and more

                                  CNBC

                                  HĂ€ufige Fragen

                                  Wie hoch ist der Aktienkurs von Bluebird bio heute?

                                  Wie lautet das Tickersymbol der Bluebird bio Aktie?

                                  Steigt der Aktienkurs von BLUE?

                                  Wie lautet die Analystenempfehlung fĂŒr BLUE?

                                  Was ist die Marktkapitalisierung von BLUE?

                                  Veröffentlicht BLUE Finanzberichte?

                                  Wann ist der nĂ€chste Termin fĂŒr die BLUE Gewinnberichte?

                                  Was waren die BLUE Gewinne im letzten Quartal?

                                  Was war der Umsatz von BLUE im letzten Quartal?

                                  Was war der Nettogewinn von BLUE im letzten Quartal?

                                  Zahlt BLUE Dividenden?

                                  Wie viele Mitarbeiter hat BLUE?

                                  Was ist BLUE EBITDA?

                                  Wie kaufe ich BLUE Aktien?

                                  Sollte ich in BLUE Aktien investieren?